Get a weekly summary of what Congress did, delivered every Sunday.

  • About
  • How Congress Works
  • Quiz
  • Congress Wrapped
  • Support Us
  • Roadmap
  • Health
  • Privacy Policy
  • Terms of Service
WhiteHouse.wiki•SCOTUS.wiki
Congress.wiki Alpha

This is not an official government website.

© 2026 PLEJ LC. All rights reserved.

Map
Live
Schedule
Daily Record
Special Rules
Subpoenas
Foreign Influence
Agencies
Regulations
Office Spending
US Code
Open search

Federal Regulations

How Congress's laws become real-world rules. Browse regulatory dockets from Regulations.gov — tracking rulemaking activity, public comment periods, and the agencies turning legislation into policy.

Dockets
6,215
Regulations.gov

Showing 30 of 6,215 dockets

Rulemaking
IRS
Open for Comments

IRS-2026-0265

Removal of Final Regulations Identifying Certain Partnership Related-Party Basis Adjustment Transactions as Transactions of Interest (REG-108921-25)

1 doc10 comments
Comments due Apr 7, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2026-D-1256

Considerations for the use of the Plausible Mechanism Framework to Develop Individualized Therapies that Target Specific Genetic Conditions with Known Biological Cause; Draft Guidance for Industry; Availability

2 docs40 comments
Comments due Apr 28, 2026
Nonrulemaking
FAA
Open for Comments

FAA-2026-3931

Triple J Drone Spraying Services LLC - Exemption/Rulemaking

1 docNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2023-2405

Signature Farms, LLC - Exemption/Rulemaking

6 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-3736

Aerocrop Applicators LLC - Exemption/Rulemaking

2 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-3780

PM Aerial Ag & Farming LLC - Exemption/Rulemaking

3 docsNo comments
Rulemaking
EPA

EPA-R01-OAR-2025-0915

Air Plan Approval; Rhode Island; Regional Haze State Implementation Plan for the Second Implementation Period

38 docsNo comments
Nonrulemaking
DOT
Open for Comments

DOT-OST-2025-1922

Parata Air Inc. - Foreign Air Carrier Permit/Exemption - US-Republic of Korea Open Skies

4 docsNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2026-D-0207

E22 General Considerations for Patient Preference Studies; International Council for Harmonisation; Draft Guidance for Industry; Availability

2 docs12 comments
Comments due Apr 8, 2026
Nonrulemaking
PTO

PTO-P-2026-0199

PCT Informed Examination Request Pilot Program

1 docNo comments
Rulemaking
FAA
Open for Comments

FAA-2026-1333

AD-2026-00130-T; The Boeing Company Model 757-200 and -300 series airplanes; winglets

2 docs1 comment
Comments due Apr 14, 2026
Nonrulemaking
FAA
Open for Comments

FAA-2016-0833

Boeing-Cargo Helicopter Sustainment - Exemption/Rulemaking

15 docs9 comments
Comments due Jan 3, 2024
Nonrulemaking
FAA
Open for Comments

FAA-2026-3697

Potter & Son Incorporated - Exemption/Rulemaking

3 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-3842

Cameron Oswald - Exemption/Rulemaking

3 docsNo comments
Nonrulemaking
EPA

EPA-HQ-OPPT-2018-0427

1,2-Dichloroethane; TSCA Review

119 docsNo comments
Nonrulemaking
EPA
Open for Comments

EPA-HQ-OW-2026-1090

Proposed 2026 Financial Capability Assessment for Clean Water Act Obligations

3 docs4 comments
Comments due May 27, 2026
Rulemaking
EPA

EPA-HQ-OW-2025-0322

Updated Definition of Waters of the United States

125 docsNo comments
Rulemaking
EPA
Open for Comments

EPA-HQ-OLEM-2025-1609

Protecting Public Health and Unleashing American Energy by Facilitating Scrap Tire Pile Cleanups

21 docs8 comments
Comments due May 23, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-P-6350

Requests that the FDA initiate notice-and-comment rulemaking to amend 21 CFR § 1271.90 to extend the existing regulatory exception for surplus cryopreserved embryos to surplus cryopreserved oocytes originally recovered for a woman’s own reproductive use

2 docs1 comment
Nonrulemaking
FDA
Open for Comments

FDA-2025-P-6223

Requests that the FDA rescind 21 CFR 801.109 in its entirety or substantially narrow the scope of 21 CFR 801.109 by amending it to limit prescription-only status to those devices that present a meaningful potential for harmful misuse or overdose in the absence of practitioner supervision.

2 docs1 comment
Nonrulemaking
FDA
Open for Comments

FDA-2025-P-4153

Requests that the FDA require revisions to the labeling for all over-the-counter acetaminophen-containing drug products marketed under the Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use monograph (OTC Monograph M013): (i) a revision to the “Warnings” subsection, currently found at M013.50(c)(1)(iii) in the Labeling section.

5 docs307 comments
Nonrulemaking
FDA

FDA-2026-H-1232

DAB Civil Money Penalty; CRV Management LLC, d/b/a Amigo Tropical Drive Thru 2; CLOSED 04/09/2026

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-P-3287

Request that the FDA remove the Mifepristone REMS Program, including but not limited to the Prescriber Certification, Pharmacy Certification, and Patient Agreement form for the reasons set forth below and in the Mifepristone Multistate Citizen Petition (FDA-2025-P-1576)

57 docs16 comments
Rulemaking
OPM

OPM-2025-0273

Performance Appraisal for General Schedule, Prevailing Rate, and Certain Other Employees

2 docs601 comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-P-3071

Requests that the FDA Limit the Exposure of Refined Carbohydrates used in Industrial Processing in order to Prevent Obesity, Diabetes, and Cardiovascular Disease in Children and Adults

3 docs489 comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-3731

Air Strike Drone Services LLC - Exemption/Rulemaking

2 docsNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-P-2162

Requests that absent new peer-reviewed studies or otherwise robust scientific or clinical evidence warranting such action, FDA take no action that would reduce patient access to mifepristone and/or increase the burdens associated with prescribing or dispensing mifepristone.

12 docs119 comments
Nonrulemaking
FDA

FDA-2026-H-3700

DAB Civil Money Penalty; Shahs Da LLC d/b/a Amoco / To Go

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-P-1576

Request that the FDA remove the Mifepristone REMS Program, including but not limited to the Prescriber Certification, Pharmacy Certification, and Patient Agreement form

23 docs154 comments
Rulemaking
OPM

OPM-2025-0239

Reduction in Force (RIF) Appeals

2 docs1.3K comments
  • Previous
  • Page 73 of 208
  • Next